Hello and Welcome to Patientsville.com, Your Source for all BUMETANIDE information. We are dedicated to provide You with BUMETANIDE safety information. Learn about BUMETANIDE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
BUMETANIDE Safety Reports
Total BUMETANIDE reports: 17.BUMETANIDE FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 14.
Take BUMETANIDE Side Effects Survey or Share Your BUMETANIDE Story. Read More Here.
Consumer or non-health professional from UNITED KINGDOM reported BUMETANIDE problem on Jan 18, 2007. Female patient, 67 years of age, was diagnosed with cardiovascular disorder, angiopathy and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: bradycardia, diarrhoea, hyperkalaemia, renal failure acute, shock. BUMETANIDE dosage: unknown. During the same period patient was treated with ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ENALAPRIL MALEATE, ENALAPRIL MALEATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
BUMETANIDE problem was reported by a Pharmacist from UNITED STATES on Feb 14, 2007. Male patient, weighting 206.0 lb, was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, balance disorder, dizziness. BUMETANIDE dosage: 2 MG DAILY. During the same period patient was treated with CLONIDINE, FELODIPINE, FLUOXETINE, LABETALOL, SPIRONOLACTONE, ACETAMINOPHEN, ALBUTEROL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from NETHERLANDS reported BUMETANIDE problem on Feb 12, 2007. Female patient, 55 years of age, weighting 163.1 lb, was diagnosed with cardiac failure, atrial fibrillation and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: dry mouth, headache, memory impairment, photophobia, photosensitivity reaction, skin discolouration. BUMETANIDE dosage: 1 MG, QD, ORAL. During the same period patient was treated with SPIRONOLACTONE, CORDARONE, SELOKEEN ZOC, NEWACE, ACENOCOUMAROL, CRESTOR. Patient recovered.
BUMETANIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 06, 2007. Female patient, 67 years of age, was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: bradycardia, diarrhoea, hyperkalaemia, renal failure acute, shock. BUMETANIDE dosage: unknown. During the same period patient was treated with ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ENALAPRIL MALEATE, ENALAPRIL MALEATE, BISOPROLOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported BUMETANIDE problem on Apr 09, 2007. Female patient, 65 years of age, weighting 222.0 lb, was diagnosed with fluid retention and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: epistaxis, pneumonia, pulmonary oedema, sinus headache. BUMETANIDE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
BUMETANIDE problem was reported by a Pharmacist from UNITED STATES on May 04, 2007. Male patient, weighting 208.0 lb, was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, renal disorder. BUMETANIDE dosage: 1 MG BID PO. During the same period patient was treated with METOLAZONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported BUMETANIDE problem on May 22, 2007. Female patient, 65 years of age, weighting 229.1 lb, was diagnosed with fluid retention and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, epistaxis, haemoptysis, pneumonia, sinus headache. BUMETANIDE dosage: 1 MG, BID, ORAL. During the same period patient was treated with ADVAIR DISKUS, INSULIN, LEVOTHYROXINE, LIPITOR, PLAQUENIL, WARFARIN. Patient was hospitalized. Patient recovered.
BUMETANIDE problem was reported by a Consumer or non-health professional from IRELAND on June 12, 2007. Male patient, 59 years of age, was diagnosed with ill-defined disorder, diabetic neuropathy and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure chronic. BUMETANIDE dosage: DAILY DOSE: 2 MILLIGRAM(S). During the same period patient was treated with PREGABALIN, METOPROLOL SUCCINATE, DIGOXIN, WARFARIN, PRAVASTATIN, INSULIN, METFORMIN. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported BUMETANIDE problem on July 27, 2006. Female patient, 91 years of age, was diagnosed with hypertension, osteoarthritis and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, blood potassium increased, blood urea increased, fall, renal failure, therapeutic agent toxicity. BUMETANIDE dosage: unknown. During the same period patient was treated with IBUPROFEN, SPIRONOLACTONE, DIGOXIN, DICLOFENAC. Patient was hospitalized. Patient died on 05/31/2006.
BUMETANIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 04, 2006. Female patient, 91 years of age, was diagnosed with hypertension, osteoarthritis and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: fall, renal failure, therapeutic agent toxicity. BUMETANIDE dosage: unknown. During the same period patient was treated with DICLOFENAC, IBUPROFEN, SPIRONOLACTONE, DIGOXIN. Patient was hospitalized. Patient died.
Pharmacist from UNITED STATES reported BUMETANIDE problem on Aug 16, 2006. Female patient was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: anxiety, chest discomfort, chest pain, electrocardiogram st segment elevation, ventricular tachyarrhythmia. BUMETANIDE dosage: unknown. During the same period patient was treated with NOREPINEPHRINE BITARTRATE. Patient recovered.
BUMETANIDE problem was reported by a Physician from UNITED STATES on Sept 21, 2006. Female patient, 75 years of age, weighting 132.9 lb, was diagnosed with cardiac failure congestive, coronary artery disease, blood cholesterol increased and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure acute. BUMETANIDE dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, CARVEDILOL, DIGOXIN, ASPIRIN, ISOSORBIDE DINITRATE, ATORVASTATIN CALCIUM, HYDRALAZINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported BUMETANIDE problem on July 27, 2006. Female patient, 91 years of age, was diagnosed with hypertension, osteoarthritis and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, blood potassium increased, blood urea increased, fall, renal failure, therapeutic agent toxicity. BUMETANIDE dosage: unknown. During the same period patient was treated with IBUPROFEN, SPIRONOLACTONE, DIGOXIN, DICLOFENAC. Patient was hospitalized. Patient died on 05/31/2006.
BUMETANIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 11, 2006. Female patient, 91 years of age, was diagnosed with hypertension, osteoarthritis, atrial fibrillation and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: fall, renal failure, therapeutic agent toxicity. BUMETANIDE dosage: unknown. During the same period patient was treated with DICLOFENAC, SPIRONOLACTONE, DIGOXIN. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED KINGDOM reported BUMETANIDE problem on Oct 11, 2006. Female patient, 91 years of age, was diagnosed with hypertension, osteoarthritis, ill-defined disorder, atrial fibrillation and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased, electrolyte imbalance, renal failure. BUMETANIDE dosage: unknown. During the same period patient was treated with DICLOFENAC, IBUPROFEN, SPIRONOLACTONE, DIGOXIN. Patient was hospitalized. Patient died.
BUMETANIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Male patient, 80 years of age, weighting 220.7 lb, was diagnosed with hypertension and was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: dehydration, hypokalaemia. BUMETANIDE dosage: 2MG BID PO. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported BUMETANIDE problem on Sept 07, 2007. Female patient, 67 years of age, was treated with BUMETANIDE. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic decreased, bradycardia, diarrhoea, hyperkalaemia, renal failure acute, shock, unresponsive to stimuli. BUMETANIDE dosage: unknown. During the same period patient was treated with ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ENALAPRIL MALEATE, ENALAPRIL MALEATE, BISOPROLOL. Patient was hospitalized. Patient recovered.